Bastide Le Confort Medical


14/05/20 -"Considering that Bastide operates c.92% of its business in France and the nationwide lockdown should weigh on the group's Q4 20 (April-June) performance as c.25% of total revenues comes from store ..."

Pages
50
Language
English
Published on
14/05/20
You may also be interested by these reports :
18/03/24
DiaSorin’s 2023 results were in line with street expectations, however the profitability guidance miss disappointed investors. Healthy performance by ...

14/03/24
Q4 sales met the street’s expectations. Industrial Applications reported strong growth and Clinical Applications ended on a decent note, despite ...

12/03/24
First take: Growing profitability with 3-18% beat on expectations

08/03/24
When we last teased on Elekta’s (BUY; Sweden) investment case in October 2022, Elekta grabbed the investors’ much-needed attention (up >35% since ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO